February 3, 2026 February 3, 2026Categories News StoriesECOG-ACRIN legacy lung cancer studies E1594 and E5508 cited in ASCO Living Guideline 2026.3.0, therapy for stage 4 NSCLC without driver alterations
January 31, 2026 January 31, 2026Categories Announcements News StoriesThe January 2026 News from ECOG-ACRIN blog is now available
December 22, 2025 December 22, 2025Categories Announcements News StoriesThe December 2025 News from ECOG-ACRIN blog is now available
October 17, 2025 October 17, 2025Categories Announcements News StoriesThe October 2025 News from ECOG-ACRIN blog is now available
September 19, 2025 September 19, 2025Categories News StoriesWATCH: Dr. John Varlotto discusses results from study EA5181 at World Conference on Lung Cancer
September 19, 2025 September 19, 2025Categories News StoriesWATCH: Dr. David Gerber discusses E4512 ALCHEMIST trial data at World Conference on Lung Cancer
September 9, 2025 September 9, 2025Categories News StoriesDr. Suzanne Cole on using real-world data to improve the generalizability of clinical trial results (highlights PrE1702 and EA5182)
September 8, 2025 September 8, 2025Categories News StoriesEA5181 trial finds no survival benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable non-small cell lung cancer
August 6, 2025 August 6, 2025Categories News StoriesTreatment headway gives much-needed hope in small-cell lung cancer (discusses EA5161 and other trials)
